Have a personal or library account? Click to login

Preparation and evaluation of chitosan based thermoreversible gels for intraperitoneal delivery of 5-fluorouracil (5-FU)

Acta Pharmaceutica
Volume 63 (2013): Issue 4 (December 2013)
By:
Open Access
|Dec 2013

References

  1. 1. S. C. Sweetman, Martindale the Complete Drug Reference (Ed. S. C. Sweetman), 34th ed., Pharmaceutical Press, London 2005, pp. 554-556.
    Search in Google Scholar
  2. 2. E. Reed, J. Jacob, R. F. Ozols, R. C. Young and C. Allegra, 5-Fluorouracil (5-FU) and leucovorin in platinum-refractory advanced stage ovarian carcinoma, Gynecol. Oncol. 46 (1992) 326-329; DOI: 10.1016/0090-8258(92)90226-9.10.1016/0090-8258(92)90226-9
    Search in Google Scholar
  3. 3. www.rxlist.com, accessed on 25th July 2011.
    Search in Google Scholar
  4. 4. A. Goodman and L. Gilman, Antineoplastic Agents, in Manual of Pharmacology and Therapeutics (Ed. K. Parker), 11th ed., McGraw Hill, New York 2008, pp. 874-876.
    Search in Google Scholar
  5. 5. M. Markman, Intraperitoneal antineoplastic drug delivery: rationale and results, Lancet Oncol. 4 (2003) 277-283; DOI: 10.1016/S1470-2045(03)01074-X.10.1016/S1470-2045(03)01074-X
    Search in Google Scholar
  6. 6. A. Chenite, M. Buschmann, D. Wang, C. Chaput and N. Kandani, Rheological characterisation of thermogelling chitosan/glycerol-phosphate solutions, Carbohydr. Polym. 46 (2001) 39-47; DOI: 10.1016/S0144-8617(00)00281-2.10.1016/S0144-8617(00)00281-2
    Search in Google Scholar
  7. 7. W. Jie, S. Zhi-Guo and M. Guang-Hui, A thermo- and pH-sensitive hydrogel composed of quaternized chitosan/glycerophosphate, Int. J. Pharm. 315 (2006) 1-11; DOI: 10.1016/j.ijpharm.2006.01.04.
    Search in Google Scholar
  8. 8. Y. Wang, N. Xu, Q. Luo, Y. Li, L. Sun, H. Wang, K. Xu, B. Wang and Y. Zhen, In vivo assessment of chitosan/â-glycerophosphate as a new liquid embolic agent, Interv. Neuroradiol. 17 (2011) 87-92.10.1177/159101991101700114
    Search in Google Scholar
  9. 9. E. Ruel-Gariepy and L. Jean-Christophe, In situ-forming hydrogels-review of temperature-sensitive systems, Eur. J. Pharm. Biopharm. 58 (2004) 409-426; DOI: 10.1016/j.ejpb.2004.03.019.10.1016/j.ejpb.2004.03.019
    Search in Google Scholar
  10. 10. E. Ruel-Gariepy, A. Chenite, C. Chaput, S. Guirguis and J. Leroux, Characterization of thermosensitive chitosan gels for the sustained delivery of drugs, Int. J. Pharm. 203 (2000) 89-98; DOI: 10.1016/S0378-5173(00)00428-2.10.1016/S0378-5173(00)00428-2
    Search in Google Scholar
  11. 11. OECD guideline 425 for the testing of chemicals. Section 4, Acute Oral Toxicity: Up-and-Down Procedure.
    Search in Google Scholar
  12. 12. G. Carlsson, B. Gullberg and L. Hafstrom, Estimation of liver tumor volume using different formulas - an experimental study in rats, J. Cancer Res. Clin. Oncol. 105 (1983) 20-23; DOI: 10.1007/ BF00391826.10.1007/BF00391826
    Search in Google Scholar
  13. 13. M. M. Tomayko and C. P. Reynolds, Determination of subcutaneous tumor size in athymic (nude) mice, Cancer Chemother. Pharmacol. 24 (1989) 148-154; DOI: 10.1007/BF00300234.10.1007/BF00300234
    Search in Google Scholar
  14. 14. B. Jeong, S. W. Kim and Y. H. Bae, Thermosensitive sol-gel reversible hydrogels, Adv. Drug Deliv. Rev. 54 (2002) 37-51; DOI: 10.1016/S0169-409X(01)00242-3.10.1016/S0169-409X(01)00242-3
    Search in Google Scholar
  15. 15. F. Ganji, M Abdekhodaie and S. A. Ramazani, Gelation time and degradation rate of chitosan- -based injectable hydrogel, J. Sol-Gel Sci. Tech. 42 (2007) 47-53; DOI: 10.1007/s10971-006-9007-1.10.1007/s10971-006-9007-1
    Search in Google Scholar
  16. 16. D. Anderson and D. M. Conning, Experimental Toxicology: the Basic Issues, 2nd ed., Royal Society of Chemistry, California 1993, p. 17.
    Search in Google Scholar
  17. 17. A. M. Fan, L. W. Chang, Toxicology and Risk Assessment; Principles, Methods and Application, 4th ed., Marcel Dekker Inc., New York 1996, pp. 108-110.
    Search in Google Scholar
  18. 18. J. L. Speyer, P. H. Sugarbaker, J. M. Collins, R. L. Dedrick, R. W. Klecker and C. E. Myers, Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans, Cancer Res. 41 (1981) 1916-1922.
    Search in Google Scholar
  19. 19. M. J. Ellenhorn, Ellenhorn’s Medicinal Toxicology; Diagnosis and Treatment of Human Poisoning (Ed. M. J. Ellenhorn), 2nd ed., Williams and Wilkins, Baltimore 1997, p. 1326.
    Search in Google Scholar
  20. 20. R. L. Schilsky, K. E. Choi, J. Grayhack, D. Grimmer, C. Guarnieri and L. Fullem, Phase I clinical and pharmacologic study of intraperitoneal cisplatin and fluorouracil in patients with advanced intra-abdominal cancer, J. Clin Oncol. 8 (1990) 2054-2061.10.1200/JCO.1990.8.12.2054
    Search in Google Scholar
  21. 21. M. Ravi Kumar, R. Muzzarelli and C. Muzzarelli, Chitosan chemistry and pharmaceutical perspectives, Chem. Rev. 104 (2004) 6017-6084; DOI: 10.1002/chin.200511296.10.1002/chin.200511296
    Search in Google Scholar
  22. 22. R. Zange, Y. Li and T. Kissel, Biocompatibility testing of ABA triblock copolymers consisting of poly (L-lactic-co-glycolic acid) A blocks attached to a central poly(ethylene oxide) B block under in vitro conditions using different L929 mouse fibroblasts cell culture models, J. Control. Release 56 (1998) 249-258; DOI: 10.1016/S0168-3659(98)00093-5.10.1016/S0168-3659(98)00093-5
    Search in Google Scholar
  23. 23. R. Ahmadi, M. Zhou, J. D. De Bruijn, The use of thermo-sensitive chitosan as an injectable carrier for bone tissue engineering, Eur. Cell Mater. 10 (2005) 61.
    Search in Google Scholar
DOI: https://doi.org/10.2478/acph-2013-0033 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 479 - 491
Published on: Dec 31, 2013
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
chitosan,
glycerophosphate,
thermoreversible gels,
intraperitoneal,
5-fluorouracil
Related subjects:
Pharmacy,
Pharmacy, other

© 2013 Bhavesh P. Depani, Anuja A. Naik, Hema A. Nair, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Previous articleVolume 63 (2013): Issue 4 (December 2013)Next article